When Minutes Matter: How Hologic Technology Changed Our ER’s Response to a Critical Case

The Call That Changed My Shift

It was a Tuesday around 2 PM — the kind of quiet afternoon that makes you suspicious in an ER. I was reviewing lab results when the charge nurse flagged me. A 58-year-old woman was being rushed in from a nearby imaging center. She’d had a routine screening mammogram that morning. The radiologist saw something that made them send her directly to us.

From the outside, this looks like a straightforward referral. The reality is, in community hospitals like mine, the distance between an imaging finding and an actionable diagnosis can be a minefield of delays. That patient’s chart was thin — no prior imaging at our facility, a vague history of hypertension, and a note that said 'suspicious calcifications, left breast.'

We had maybe 45 minutes before the next steps would be critical. That’s when I realized how much our equipment choices matter. And that’s where Hologic came in.

The Mammography Advantage (Not Just Better Pictures)

People assume that all mammography machines are essentially the same — they take pictures of breast tissue. What they don’t see is the difference in workflow and diagnostic confidence that a system like Hologic’s 3D mammography (genius digital diagnostics) brings to a high-stakes situation.

This patient’s outside images were 2D. They showed a cluster of microcalcifications, but the depth and structure were ambiguous. Our team decided to repeat the scan using our Hologic 3D unit (not that we had much choice — it’s all we use). The difference was immediate. The 3D images showed a spiculated mass that was hidden in the 2D slices. It was clearly more than a benign cluster. Our radiologist could confidently recommend a biopsy right there, rather than a repeat in six months.

To be fair, the old 2D technology was adequate for screening. But in a case like this — where the clock is ticking on a potential diagnosis — the clarity of Hologic’s imaging saved us at least one additional appointment and two weeks of patient anxiety. That’s the kind of time you can’t buy back.

Pulse Oximetry and the Unexpected Complication

While we were planning the biopsy, the patient’s oxygen saturation started dropping. Not dramatically — from 98% to 94% over about 20 minutes. She was asymptomatic, but in an ER, you don’t ignore trends.

Our standard pulse oximeter was a basic model from a different vendor. It showed the drop, but the waveform was noisy and unreliable. I switched her to a Hologic bedside monitor (I know Hologic is primarily known for imaging, but their patient monitoring line is solid). The waveform was cleaner, and the alarm thresholds were easier to set for this specific scenario.

We discovered she had a small pulmonary embolism — likely from a recent long-haul flight. The oximeter data, combined with the cleaner signal, gave us the confidence to start anticoagulation immediately. If we had waited for a formal CT scan (which would have taken another 90 minutes), she might have deteriorated.

My experience with pulse oximeters is based on hundreds of cases in a busy ER. If you’re working with a purely surgical or outpatient clinic setting, your needs might differ. But for acute care, the difference between a 'good enough' oximeter and one that provides clean, reliable waveforms is the difference between watching a trend and acting on it.

How Does a CGM Work? (An Unexpected Learning Moment)

The patient also had a history of type 2 diabetes, managed by diet and metformin. Her blood glucose was 165 mg/dL on admission — elevated but not alarming. But her family was anxious. Her daughter asked me, 'How does a CGM work? Should she be on one?'

I had to pause. I’m an ER doctor, not an endocrinologist. But I’ve learned enough from our own patients and from recent literature (which, honestly, has exploded since 2022). A continuous glucose monitor (CGM) uses a tiny sensor inserted under the skin, usually on the arm or abdomen. It measures glucose in the interstitial fluid every few minutes, transmitting data to a receiver or smartphone. The key advantage is seeing the direction of change, not just a single number. It can warn about hypoglycemia hours before it becomes dangerous.

This was true five years ago when CGM was mostly for type 1 diabetes. Today, models like the Dexcom G7 and Freestyle Libre 3 are widely prescribed for type 2 as well, especially for patients on insulin or with history of hypoglycemia. This patient wasn’t on insulin, but she was at risk. I recommended she follow up with her endocrinologist to discuss it.

That moment reminded me that the fundamentals of good medicine haven't changed — context, history, and listening to patients — but the tools we use to execute have transformed. A CGM is a perfect example of that evolution.

The Minerva Surgical Perspective (Why We Don't Always Choose the Newest)

During the case review later that week, our team discussed the Minerva Surgical v. Hologic patent litigation. It’s a topic I’ve had to brush up on for credentialing meetings. Minerva makes a system for endometrial ablation, and Hologic has its own version (NovaSure). The legal dispute was about patents, not clinical outcomes. But it highlights a useful buying principle:

When choosing between two similar devices from rival companies, don’t assume the newer or the one with more press is better. Look at the evidence base. Hologic’s NovaSure has been on the market for over 20 years, with hundreds of studies backing its safety and efficacy. Minerva’s system is newer and has a smaller evidence base. That doesn’t make it worse — but it’s a risk-reward calculation. For high-acuity, time-sensitive cases, I want the device with the longer track record.

This was true a decade ago when the device market was more fragmented. Today, the consolidation of device companies means that often the safer choice is the one with the longest clinical history.

What I Learned That Tuesday

The patient had her biopsy the next morning. It showed early-stage ductal carcinoma in situ (DCIS). She’ll need surgery and possibly radiation, but the prognosis is excellent. I credit the Hologic 3D mammography for giving us the confidence to act fast, and the reliable pulse oximeter for catching the PE before it became a crisis.

My experience is based on one case in one ER. If you’re working in a different setting — say, a pure outpatient imaging center or a rural clinic with limited resources — your priorities might be different. But the principle holds: the best device is the one that gives you the clearest signal, the fastest, in the most critical moment.

That day, Hologic’s devices did that. Not because they were the most expensive or the most advertised, but because they were the ones that gave us the information we needed, when we needed it.